Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-17
DOI
10.1111/jdi.13148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin
- (2018) Ahmet Cagdas Acara et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- A preclinical overview of metformin for the treatment of type 2 diabetes
- (2018) Tingting Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
- (2018) Yuren Wang et al. MEDIATORS OF INFLAMMATION
- A Spotlight on Appetite
- (2018) Lisa R. Beutler et al. NEURON
- Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome
- (2018) Murat Alan et al. GYNECOLOGICAL ENDOCRINOLOGY
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
- (2018) Magdalena Wiecek et al. Frontiers in Physiology
- Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes
- (2017) María Molina Vega et al. Expert Opinion on Drug Metabolism & Toxicology
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Advances in the understanding of adipose tissue biology
- (2017) Shingo Kajimura Nature Reviews Endocrinology
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Asprosin — new hormone involved in hepatic glucose release
- (2016) Claire Greenhill Nature Reviews Endocrinology
- Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
- (2013) Quan Zhang et al. Cell Metabolism
- Brain glucose sensing and neural regulation of insulin and glucagon secretion
- (2011) B. Thorens DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More